Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 8343 participants.

Also called NCT05439356

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 8,343 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05439356
Other papers using this trial's data
  • Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial BMJ (Clinical research ed.), 2024-06-26 DOI, PubMed 38925803, PMC11200154 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05439356. Randomized; quadruple masking; primary purpose prevention. Start 2022-08-11 (actual); primary completion 2023-07-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo colchicine
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct05439356
Content hash
fb0c7b0b38db1c7bc043cbf49ac1cd5b1f0eca2372126220b7fbd9ce110a1870